No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancer.
S I ShermanR T KloosR M TuttleA PontecorviH VölzkeK HarperC VanceJ T AlstonA L UsborneK W SloopMark LakshmananPublished in: Diabetic medicine : a journal of the British Diabetic Association (2018)
The tumour was not considered stimulated by dulaglutide therapy because calcitonin remained stable throughout.
Keyphrases